GERN
Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Geron Corp (GERN)Equibles does not estimate personal net worth.
Get an email with a short summary when Geron Corp publishes a filing, an earnings call transcript or a press release.
Get GERN alertsAron Feingold is recorded as Head of Investor Relations at Geron Corp (GERN). Aron Feingold has spoken on 11 earnings calls across 1 company, most recently for Geron Corp on January 13, 2025. Geron Corp is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Geron Corp includes Elizabeth G. O'Farrell (Chairman and Board Member), Michelle J. Robertson (CFO), Shanthakumar Tyavanagimatt (CTO) and 7 others.
“Welcome to the Geron Corporation fourth quarter and full year 2024 earnings conference call. I am Aron Feingold, Geron's Vice President of Investor Relations and Corporate Communications.”
“I'm joined today by several members of Geron's management team.”
“I'm joined today by several members of Geron's management team.”
“I'm joined today by several members of Geron's management team, Dr. John Scarlett, Chairman and Chief Executive Officer; Anil Kapur, Executive Vice President of Corporate Strategy and Chief Commercial Officer; Dr. Faye Feller, Executive Vice President and Chief Medical Officer; Michelle Robertson, Executive Vice…”
“Welcome to the Geron Corporation fourth quarter and full year 2023 earnings conference call. I am Aron Feingold, Geron's Vice President of Investor Relations and Corporate Communication.”
GERN
Biotechnology · Healthcare
Head of Investor Relations